User profiles for "author:Bolland W"
 | William BollandInstitut Pasteur Verified email at pasteur.fr Cited by 3412 |
Considerable escape of SARS-CoV-2 Omicron to antibody neutralization
Abstract The SARS-CoV-2 Omicron variant was first identified in November 2021 in
Botswana and South Africa,–. It has since spread to many countries and is expected to …
Botswana and South Africa,–. It has since spread to many countries and is expected to …
Preexisting and de novo humoral immunity to SARS-CoV-2 in humans
KW Ng, N Faulkner, GH Cornish, A Rosa, R Harvey… - Science, 2020 - science.org
Zoonotic introduction of novel coronaviruses may encounter preexisting immunity in
humans. Using diverse assays for antibodies recognizing SARS-CoV-2 proteins, we …
humans. Using diverse assays for antibodies recognizing SARS-CoV-2 proteins, we …
Distinct evolution of SARS-CoV-2 Omicron XBB and BA. 2.86/JN. 1 lineages combining increased fitness and antibody evasion
The unceasing circulation of SARS-CoV-2 leads to the continuous emergence of novel viral
sublineages. Here, we isolate and characterize XBB. 1, XBB. 1.5, XBB. 1.9. 1, XBB. 1.16. 1 …
sublineages. Here, we isolate and characterize XBB. 1, XBB. 1.5, XBB. 1.9. 1, XBB. 1.16. 1 …
Serum neutralization of SARS-CoV-2 Omicron sublineages BA. 1 and BA. 2 in patients receiving monoclonal antibodies
The severe acute respiratory syndrome coronavirus 2 Omicron BA. 1 sublineage has been
supplanted in many countries by the BA. 2 sublineage. BA. 2 differs from BA. 1 by about 21 …
supplanted in many countries by the BA. 2 sublineage. BA. 2 differs from BA. 1 by about 21 …
[HTML][HTML] Longitudinal analysis of serum neutralization of SARS-CoV-2 Omicron BA. 2, BA. 4, and BA. 5 in patients receiving monoclonal antibodies
The emergence of Omicron sublineages impacts the therapeutic efficacy of anti-severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) monoclonal antibodies (mAbs) …
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) monoclonal antibodies (mAbs) …
Structural basis of TMPRSS2 zymogen activation and recognition by the HKU1 seasonal coronavirus
The human seasonal coronavirus HKU1-CoV, which causes common colds worldwide,
relies on the sequential binding to surface glycans and transmembrane serine protease 2 …
relies on the sequential binding to surface glycans and transmembrane serine protease 2 …
Considerable escape of SARS-CoV-2 variant Omicron to antibody neutralization
D Planas, N Saunders, P Maes, F Guivel-Benhassine… - BioRxiv, 2021 - biorxiv.org
The SARS-CoV-2 Omicron variant was first identified in November 2021 in Botswana and
South Africa,. It has in the meantime spread to many countries and is expected to rapidly …
South Africa,. It has in the meantime spread to many countries and is expected to rapidly …
Tissue-specific and interferon-inducible expression of nonfunctional ACE2 through endogenous retroelement co-option
Abstract Angiotensin-converting enzyme 2 (ACE2) is an entry receptor for severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) and a regulator of several physiological …
respiratory syndrome coronavirus 2 (SARS-CoV-2) and a regulator of several physiological …
Reduced antibody cross-reactivity following infection with B. 1.1. 7 than with parental SARS-CoV-2 strains
Background: The degree of heterotypic immunity induced by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) strains is a major determinant of the spread of …
syndrome coronavirus 2 (SARS-CoV-2) strains is a major determinant of the spread of …
[HTML][HTML] Duration of BA. 5 neutralization in sera and nasal swabs from SARS-CoV-2 vaccinated individuals, with or without omicron breakthrough infection
D Planas, I Staropoli, F Porot, F Guivel-Benhassine… - Med, 2022 - cell.com
Summary Background Since early 2022, Omicron BA. 1 has been eclipsed by BA. 2, which
was in turn outcompeted by BA. 5, which displays enhanced antibody escape properties …
was in turn outcompeted by BA. 5, which displays enhanced antibody escape properties …